Med-tech firms raising money in public or private financings, including: Cryosa, Garuda Therapeutics, Lucid Diagnostics, Thorne Healthtech.

Biopharmas raising money in public or private financings, including: Garuda, Genedit, Synlogic.

Biopharmas raising money in public or private financings, including: Leap, Opus, Oxford, RD Fund, Serum.

Biopharmas raising money in public or private financings, including: Atyr, Fauna, Galectin, Galapagos, Mycrodose, Viridian.

Biopharmas in Asia-Pacific raising money in public or private financings: Alebund, Etana, Iaso, Innovent.

Med-tech firms raising money in public or private financings, including: Aurora Spine, Evisit, Pager, Symphonycare, Xealth.

LONDON – There were well-deserved celebrations in Paris on Sept. 20, as Jeito Capital toasted the oversubscribed close of its first fund at €534 million (US$625.5 million). This is claimed as the largest European venture fund dedicated to life sciences, exceeding the original target of €500 million, and with €340 million of the total raised under the constraints of the pandemic from January 2020 onward.